目次

Executive Summary
Market Overview

Market Landscape
Market ecosystem
Value chain analysis

Market Sizing
Market definition
Market segment analysis
Market size 2021
Market outlook: Forecast for 2021 - 2026

Five Forces Analysis
Five Forces Summary
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition

Market Segmentation by Type
Market segments
Comparison by Type
Advanced injectable drug delivery devices - Market size and forecast 2021-2026
Conventional injectable drug delivery devices - Market size and forecast 2021-2026
Market opportunity by Type

Customer landscape
Overview

Geographic Landscape
Geographic segmentation
Geographic comparison
North America - Market size and forecast 2021-2026
Europe - Market size and forecast 2021-2026
Asia - Market size and forecast 2021-2026
ROW - Market size and forecast 2021-2026
Key leading countries
Market opportunity by geography

Drivers, Challenges, and Trends
Market drivers
Market challenges
Market trends

Vendor Landscape
Overview
Landscape disruption
Competitive landscape

Vendor Analysis
Vendors covered
Market positioning of vendors
AstraZeneca Plc
Baxter International Inc.
Becton Dickinson and Co.
Eli Lilly and Co.
Gerresheimer AG
Owen Mumford Ltd.
Sanofi SA
SCHOTT AG
Teva Pharmaceutical Industries Ltd.
Viatris Inc.

Appendix
Scope of the report
Currency conversion rates for US$
Research Methodology
List of abbreviations

Exhibits
1: Key Finding 1
2: Key Finding 2
3: Key Finding 3
4: Key Finding 5
5: Key Finding 6
6: Key Finding 7
7: Key Finding 8
8: Parent market
9: Market characteristics
10: Offerings of vendors included in the market definition
11: Market segments
12: Global - Market size and forecast 2021 - 2026 ($ million)
13: Global market: Year-over-year growth 2021 - 2026 (%)
14: Five forces analysis 2021 & 2026
15: Bargaining power of buyers
16: Bargaining power of suppliers
17: Threat of new entrants
18: Threat of substitutes
19: Threat of rivalry
20: Market condition - Five forces 2021
21: Type - Market share 2021-2026 (%)
22: Comparison by Type
23: Advanced injectable drug delivery devices - Market size and forecast 2021-2026 ($ million)
24: Advanced injectable drug delivery devices - Year-over-year growth 2021-2026 (%)
25: Conventional injectable drug delivery devices - Market size and forecast 2021-2026 ($ million)
26: Conventional injectable drug delivery devices - Year-over-year growth 2021-2026 (%)
27: Market opportunity by Type
28: Customer landscape
29: Market share by geography 2021-2026 (%)
30: Geographic comparison
31: North America - Market size and forecast 2021-2026 ($ million)
32: North America - Year-over-year growth 2021-2026 (%)
33: Europe - Market size and forecast 2021-2026 ($ million)
34: Europe - Year-over-year growth 2021-2026 (%)
35: Asia - Market size and forecast 2021-2026 ($ million)
36: Asia - Year-over-year growth 2021-2026 (%)
37: ROW - Market size and forecast 2021-2026 ($ million)
38: ROW - Year-over-year growth 2021-2026 (%)
39: Key leading countries
40: Market opportunity by geography ($ million)
41: Impact of drivers and challenges
42: Vendor landscape
43: Landscape disruption
44: Industry risks
45: Vendors covered
46: Market positioning of vendors
47: AstraZeneca Plc - Overview
48: AstraZeneca Plc - Product and service
49: AstraZeneca Plc - Key offerings
50: AstraZeneca Plc - Key customers
51: AstraZeneca Plc - Segment focus
52: Baxter International Inc. - Overview
53: Baxter International Inc. - Business segments
54: Baxter International Inc. - Key offerings
55: Baxter International Inc. - Key customers
56: Baxter International Inc. - Segment focus
57: Becton Dickinson and Co. - Overview
58: Becton Dickinson and Co. - Business segments
59: Becton Dickinson and Co. - Key offerings
60: Becton Dickinson and Co. - Key customers
61: Becton Dickinson and Co. - Segment focus
62: Eli Lilly and Co. - Overview
63: Eli Lilly and Co. - Business segments
64: Eli Lilly and Co. - Key offerings
65: Eli Lilly and Co. - Key customers
66: Eli Lilly and Co. - Segment focus
67: Gerresheimer AG - Overview
68: Gerresheimer AG - Business segments
69: Gerresheimer AG - Key offerings
70: Gerresheimer AG - Key customers
71: Gerresheimer AG - Segment focus
72: Owen Mumford Ltd. - Overview
73: Owen Mumford Ltd. - Product and service
74: Owen Mumford Ltd. - Key offerings
75: Owen Mumford Ltd. - Key customers
76: Owen Mumford Ltd. - Segment focus
77: Sanofi SA - Overview
78: Sanofi SA - Business segments
79: Sanofi SA - Key offerings
80: Sanofi SA - Key customers
81: Sanofi SA - Segment focus
82: SCHOTT AG - Overview
83: SCHOTT AG - Business segments
84: SCHOTT AG - Key offerings
85: SCHOTT AG - Key customers
86: SCHOTT AG - Segment focus
87: Teva Pharmaceutical Industries Ltd. - Overview
88: Teva Pharmaceutical Industries Ltd. - Business segments
89: Teva Pharmaceutical Industries Ltd. - Key offerings
90: Teva Pharmaceutical Industries Ltd. - Key customers
91: Teva Pharmaceutical Industries Ltd. - Segment focus
92: Viatris Inc. - Overview
93: Viatris Inc. - Business segments
94: Viatris Inc. - Key offerings
95: Viatris Inc. - Key customers
96: Viatris Inc. - Segment focus
97: Currency conversion rates for US$
98: Research Methodology
99: Validation techniques employed for market sizing
100: Information sources
101: List of abbreviations